Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> New Publication <<
March 7, 2025
Unregulated large language models produce medical device-like output. npj Digital Medicine 2025; 4:148.
>> New Publication <<
September 20, 2024
Lessons from the Change Healthcare Ransomware Attack. JAMA Health Forum 2024; 5:e242764.
Public Comment
August 13, 2024
Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]
STAT News
June 23, 2025
FDA chief’s goals of ‘radical transparency’ threatened by agency cuts [PDF]
by Lizzy Lawrence
Reuters
June 12, 2025
Kennedy’s ouster of US vaccine advisors puts pharma ties under scrutiny
by Chad Terhune
PricePod: Public Policy Conversations (podcast)
June 4, 2025
Closing the revolving door at HHS
Interview with Christian Hetrick